Syros Pharmaceuticals Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Syros Pharmaceuticals

Access the complete profile.

Syros Pharmaceuticals Fast Facts

Revenue	$100 - $500 million    See Exact Annual Revenue
Employees	100 - 500Exact Company Size
Primary Industry	325411 Medicinal & Botanical Manufacturing
Address	35 Cambridge Park Drive Cambridge, MA 02140

Note: Revenues for privately held companies are statistical evaluations.


Syros Pharmaceuticals's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Syros Pharmaceuticals's annual revenues are $100 - $500 million (see exact revenue data)
• What industry is the company in?
  • Syros Pharmaceuticals is classified as operating in the Medicinal & Botanical Manufacturing industry, NAICS Code 325411.

Syros Pharmaceuticals Annual Revenue and Growth Rate

Syros Pharmaceuticals	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2023	$100 - $500 million Details in Premium Report
2022
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Syros Pharmaceuticals's revenues are gauged from an analysis of company filings.

Syros Pharmaceuticals's Income Statement (based on Industry Averages)

Syros Pharmaceuticals P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Investor Activity

Syros Pharmaceuticals has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date	Investors	Percent Raised	Target Size
September 21, 2022	19	100%	$130 MM
Complete list of funding rounds and total amounts in the Company Report

Trademark Applications

Trademark applications show the products and services that Syros Pharmaceuticals is developing and marketing. Syros Pharmaceuticals doesn't have any recent trademark applications, indicating Syros Pharmaceuticals is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
RAZTAMRI Pharmaceutical products; pharmaceuticals for treatment of myelodysplastic syndrome; pharmaceuticals for treatment of acute myeloid leukemia, acute myelogenous leukemia, and acute nonlymphocytic leukemia	03/24/2023
SYROS pharmaceutical preparations and compounds for use in the treatment of cancer; pharmaceutical preparations and compounds for inhibition of transcriptional regulators	12/17/2012
SYROS PHARMACEUTICALS pharmaceutical preparations and compounds for use in the treatment of cancer; pharmaceutical preparations and compounds for inhibition of transcriptional regulators	12/17/2012

See all trademarks and details in the Full Report.

Market Share of Syros Pharmaceuticals's Largest Competitors

A competitive analysis shows these companies are in the same general field as Syros Pharmaceuticals, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
XYMOGEN	Orlando, FL	100
AVANTI NUTRITIONAL LABORATORIES	Miami Lakes, FL	37
NUTRITION FORMULATORS	Miramar, FL	36
RTPR	Cabot, AR	33
INTEGRATED BOTANICS	Fort Worth, TX	29
COSMAX NBT USA	Garland, TX	29
CJB INDUSTRIES	Valdosta, GA	28
ALTERNATIVE LABORATORIES	Naples, FL	28
S&B PHARMA	Azusa, CA	28

Nearby Competitors

These companies are similar in business line and location to Syros Pharmaceuticals. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
BIOGEN	Cambridge, MA	100
SAREPTA THERAPEUTICS	Cambridge, MA	36
AMYLYX PHARMACEUTICALS	Cambridge, MA	11
BRAINTREE LABORATORIES	Braintree, MA	8
FOGHORN THERAPEUTICS	Cambridge, MA	5
RECRUITMENT STRATEGIES GROUP	Stoneham, MA	4

Future Competition: Syros Pharmaceuticals's Fastest Growing Competitors

These companies are in the same general field as Syros Pharmaceuticals and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)